Prothena Corp. Plc (PRTA)
9.34
+0.25
(+2.75%)
USD |
NASDAQ |
Aug 28, 16:00
9.34
0.00 (0.00%)
After-Hours: 20:00
Prothena Free Cash Flow : -62.08M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -62.08M |
| March 31, 2026 | -86.56M |
| December 31, 2025 | -168.85M |
| September 30, 2025 | -191.50M |
| June 30, 2025 | -194.72M |
| March 31, 2025 | -128.48M |
| December 31, 2024 | -148.23M |
| September 30, 2024 | -154.91M |
| June 30, 2024 | -99.23M |
| March 31, 2024 | -161.64M |
| December 31, 2023 | -136.00M |
| September 30, 2023 | -92.62M |
| June 30, 2023 | -128.95M |
| March 31, 2023 | -116.14M |
| December 31, 2022 | -106.07M |
| September 30, 2022 | -122.10M |
| June 30, 2022 | 15.10M |
| March 31, 2022 | 85.27M |
| December 31, 2021 | 89.00M |
| September 30, 2021 | 92.67M |
| June 30, 2021 | -39.42M |
| March 31, 2021 | -94.77M |
| December 31, 2020 | -84.25M |
| September 30, 2020 | -78.42M |
| June 30, 2020 | -65.28M |
| Date | Value |
|---|---|
| March 31, 2020 | -58.57M |
| December 31, 2019 | -52.95M |
| September 30, 2019 | -60.27M |
| June 30, 2019 | -84.51M |
| March 31, 2019 | -14.86M |
| December 31, 2018 | -29.06M |
| September 30, 2018 | -47.23M |
| June 30, 2018 | -36.93M |
| March 31, 2018 | -132.14M |
| December 31, 2017 | -140.71M |
| September 30, 2017 | -138.20M |
| June 30, 2017 | -154.11M |
| March 31, 2017 | -145.41M |
| December 31, 2016 | -130.46M |
| September 30, 2016 | -113.37M |
| June 30, 2016 | -91.55M |
| March 31, 2016 | -73.65M |
| December 31, 2015 | -63.01M |
| September 30, 2015 | -54.91M |
| June 30, 2015 | -50.62M |
| March 31, 2015 | -33.75M |
| December 31, 2014 | -1.138M |
| September 30, 2014 | 0.5954M |
| June 30, 2014 | 2.503M |
| March 31, 2014 | -10.41M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Alkermes Plc | 221.65M |
| Amarin Corp. Plc | 15.55M |
| Agenus, Inc. | -98.50M |
| Amgen, Inc. | 10.18B |
| Anika Therapeutics, Inc. | 0.562M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -25.06M |
| Cash from Investing (Quarterly) | -0.6499M |
| Cash from Financing (Quarterly) | -15.50M |
| Free Cash Flow Per Share (Quarterly) | -0.4931 |
| Free Cash Flow to Equity (Quarterly) | -25.05M |
| Free Cash Flow to Firm (Quarterly) | -25.71M |
| Free Cash Flow Yield | -12.43% |